HUMAN ANTI-CXCL-10 ANTIBODIS AND RHEUMATOID ARTHRITIS-TREATING COMPOSITION THEREOF
摘要
The present invention relates to an antibody against CXCL-10 which is a chemokine causing rheumatoid arthritis and a composition containing the same for treating rheumatoid arthritis. Specifically, the present invention provides an antibody against human CXCL-10 with an amino acid sequence selected among amino acid sequences of sequence numbers 1-4 and a composition containing the same for treating rheumatoid arthritis. According to the present invention, the antibody against CXCL-10 is produced and basically treats rheumatoid arthritis which is chronic intractable rheumatoid arthritis that 1·2% of people have. [Reference numerals] (AA) CIA (10 animal models);(BB) 1.25 mg/kg anti-CXCL-10-2A (10 animal models);(CC) 2.5 mg/kg anti-CXCL-10-2A (10 animal models);(DD) 5 mg/kg anti-CXCL-10-2A (10 animal models)
申请公布号
KR20130121601(A)
申请公布日期
2013.11.06
申请号
KR20120044963
申请日期
2012.04.27
申请人
A&R THERAPEUTICS CO., LTD.
发明人
PARK, JAE EUN;JANG, MYEONG HEE;KIM, HYE NAN;PARK, YOUNG WOO;YOO, SEOK HO;SONG, YEONG WOOK;PARK, BUM CHAN;KIM, DONG JIN